Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



BAUM CHARLES M Create: Alert

All | News | Filings
Date FiledTypeDescription
08/10/2023 4 BAUM CHARLES M (Interim CEO) has filed a Form 4 on Mirati Therapeutics, Inc.
Txns: Granted 54,054 shares @ $37, valued at $2M
06/28/2023 4 BAUM CHARLES M (Director) has filed a Form 4 on Acrivon Therapeutics, Inc.
Txns: Granted 32,500 options to buy @ $12.88, valued at $418.6k
06/28/2023 3 BAUM CHARLES M (Director) has filed a Form 3 on Acrivon Therapeutics, Inc.
06/16/2023 4 BAUM CHARLES M (Director) has filed a Form 4 on Poseida Therapeutics, Inc.
Txns: Granted 19,650 shares @ $0
Granted 27,350 options to buy @ $2.47, valued at $67.6k
06/12/2023 4 BAUM CHARLES M (Director) has filed a Form 4 on PMV Pharmaceuticals, Inc.
Txns: Granted 21,500 options to buy @ $5.59, valued at $120.2k
01/24/2023 4 BAUM CHARLES M (President,Founder,Head of R&D) has filed a Form 4 on Mirati Therapeutics, Inc.
Txns: Granted 4,444 shares @ $0
Granted 7,520 options to buy @ $45.66, valued at $343.4k
01/05/2023 4 BAUM CHARLES M (President,Founder,Head of R&D) has filed a Form 4 on Mirati Therapeutics, Inc.
Txns: Sold 3,648 shares @ $46.6, valued at $170k
12/21/2022 4 BAUM CHARLES M (President,Founder,Head of R&D) has filed a Form 4 on Mirati Therapeutics, Inc.
Txns: Granted 53,618 shares @ $0
Sold 9,092 shares @ $40.4167, valued at $367.5k
11/28/2022 4 BAUM CHARLES M (President,Founder,Head of R&D) has filed a Form 4 on Mirati Therapeutics, Inc.
Txns: Sold 69,256 shares @ $100, valued at $6.9M
Exercised 69,256 options to buy @ $17.41, valued at $1.2M
06/16/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/06/2022 4 BAUM CHARLES M (Director) has filed a Form 4 on PMV Pharmaceuticals, Inc.
Txns: Granted 19,500 options to buy @ $13.56, valued at $264.4k
05/18/2022 3 Form 3 - Initial statement of beneficial ownership of securities:
01/18/2022 4 BAUM CHARLES M (President,Founder,Head of R&D) has filed a Form 4 on Mirati Therapeutics, Inc.
Txns: Granted 25,543 shares @ $0
Sold 2,517 shares @ $120.4821, valued at $303.3k
Granted 42,325 options to buy @ $124.31, valued at $5.3M
Exercised 3,703 options to buy @ $27, valued at $100k
01/06/2022 4 BAUM CHARLES M (President,Founder,Head of R&D) has filed a Form 4 on Mirati Therapeutics, Inc.
Txns: Sold 4,045 shares @ $147.73, valued at $597.6k
Sold 69 shares @ $149.085, valued at $10.3k
12/17/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/03/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/21/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/09/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/07/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/07/2021 3 Form 3 - Initial statement of beneficial ownership of securities:
01/28/2021 4 BAUM CHARLES M (President & CEO) has filed a Form 4 on Mirati Therapeutics, Inc.
Txns: Exercised 2,292 options to buy @ $5.4, valued at $12.4k
01/20/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/08/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/31/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/21/2020 4 BAUM CHARLES M (President & CEO) has filed a Form 4 on Mirati Therapeutics, Inc.
Txns: Sold 9,888 shares @ $233.4289, valued at $2.3M
Sold 22,932 shares @ $234.2577, valued at $5.4M
Sold 493 shares @ $235.2042, valued at $116k
Sold 4,250 shares @ $236.1722, valued at $1M
Sold 2,020 shares @ $237.255, valued at $479.3k
Sold 100 shares @ $238.755, valued at $23.9k
Sold 317 shares @ $240.23, valued at $76.2k
Exercised 40,000 options to buy @ $8.49, valued at $339.6k
10/23/2020 4 BAUM CHARLES M (Director) has filed a Form 4 on IMMUNOMEDICS INC
Txns: Disposed/sold 9,667 shares @ $0
Disposed/sold 46,117 options to buy @ $0
Disposed/sold 3,718 restricted stock units @ $0
09/02/2020 3 BAUM CHARLES M (Director) has filed a Form 3 on BCTG Acquisition Corp.
07/24/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/22/2020 4 BAUM CHARLES M (Director) has filed a Form 4 on IMMUNOMEDICS INC
Txns: Granted 3,718 shares @ $0
Granted 6,540 options to buy @ $33.62, valued at $219.9k
04/28/2020 4 BAUM CHARLES M (President & CEO) has filed a Form 4 on Mirati Therapeutics, Inc.
Txns: Exercised 557 options to buy @ $5.4, valued at $3k
04/20/2020 4 BAUM CHARLES M (President & CEO) has filed a Form 4 on Mirati Therapeutics, Inc.
Txns: Sold 10,526 shares @ $89.5932, valued at $943.1k
Sold 25,184 shares @ $90.4129, valued at $2.3M
Sold 4,290 shares @ $91.6299, valued at $393.1k
Exercised 40,000 options to buy @ $8.49, valued at $339.6k
03/30/2020 4 BAUM CHARLES M (President & CEO) has filed a Form 4 on Mirati Therapeutics, Inc.
Txns: Exercised 2,291 options to buy @ $5.4, valued at $12.4k
03/02/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/06/2020 4 BAUM CHARLES M (President & CEO) has filed a Form 4 on Mirati Therapeutics, Inc.
Txns: Exercised 2,291 options to buy @ $5.4, valued at $12.4k
Exercised 2,396 options to buy @ $24.99, valued at $59.9k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy